- Home
- PMO vs LFCR Comparison
PMO vs LFCR Comparison
Compare PMO & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMO | LFCR |
|---|---|---|
| Founded | 1993 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.4M | 241.8M |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PMO | LFCR |
|---|---|---|
| Price | $9.86 | $6.43 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.28 |
| AVG Volume (30 Days) | 167.5K | ★ 737.9K |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | ★ 4.10% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.47 |
| P/E Ratio | $25.02 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $8.87 | $3.63 |
| 52 Week High | $10.87 | $8.98 |
Technical Indicators
Market Signals| Indicator | PMO | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 58.91 | 72.51 |
| Support Level | $8.87 | $4.20 |
| Resistance Level | $10.56 | $6.48 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | 0.08 | -0.07 |
| Stochastic Oscillator | 92.50 | 62.50 |
Price Performance
Historical ComparisonAbout PMO Putnam Municipal Opportunities Trust
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, leases, local, Housing, education, and Others.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.